人工智能个性化手术医疗科技公司Carlsmed近日宣布，已完成由B Capital和US Venture Partners共同领投的5250万美元C轮融资。此次融资将加速推进该公司旗下个性化脊柱手术平台aprevo®的商业化应用，并用于开发将于2025年推出的颈椎融合手术版本。Carlsmed的aprevo®平台利用人工智能技术，为腰椎融合手术提供个性化解决方案，旨在提高手术效率和患者康复效果。随着资金的注入，Carlsmed有望进一步加强其在医疗科技创新领域的领导地位。
英文翻译内容：
Title: Carlsmed, an AI-powered personalized surgery medical technology company, closes $52.5 million in Series C funding
Keywords: AI in healthcare, personalized spine surgery, funding round
News content:
Carlsmed, a medical technology company that leverages AI for personalized spine surgery, has announced the completion of a $52.5 million Series C funding round, co-led by B Capital and US Venture Partners. The funding will expedite the commercialization of its aprevo® platform for lumbar fusion surgeries and the development of an aprevo® version for cervical fusion procedures, slated for launch in 2025. With this investment, Carlsmed is poised to further strengthen its leadership in medical technology innovation.
【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery
Views: 2